Expression vector of human NFKB1.
Alternative name | SET-0132_16 |
---|---|
Clone info. | Expression vector of human NFKB1. Expression has not yet been confirmed. |
Comment | PCR cloning, forward primer: gcagaagatgatccatatttgggaag; reverse primer: ctaaattttgccttctagaggtccttc. Nucleotide substitution T2603G (silent), G2222A (silent) to NM_003998.2. |
Vector backbone | pCMV_S-FLAG (RDB05956) (Plasmid) |
Size of vector backbone | 5.5 kb |
Selectable markers | Amp^r (E. coli), Neo^r (mammalian cell) |
Growth conditions | 37C, LB+Amp |
Gene/insert name | Human NFKB1 cDNA |
Depositor|Developer | DNA Bank, | |
Remarks, protocol and/or map (pdf) | RDB07018.pdf |
---|
Please check terms and conditions set forth by the depositor, which are specified in the RIKEN BRC Catalog and/or Web Catalog.
Ordering forms | Order form [Credit Card Payment ![]() ![]() ![]() MTA, for use for not-for-profit academic purpose [Word ![]() ![]() MTA, for use for for-profit purpose [Word ![]() Please visit Information of Request for Distribution.[link] |
---|---|
Terms and conditions for distribution | The RECIPIENT agrees to describe RIKEN BRC as the source of the MATERIAL in any publication. Additional terms and conditions: Regrding pRc/CMV: a) The modified pRc/CMV, and their descendants (collectively, LIFE MATERIALS), should be used for pre-clinical/non-human, research use only. b) LIFE MATERIALS shall not be used for any commercial purposes. c) LIFE MATERIALS shall not be transferred beyond the specified recipient. d) Recipient must contact Thermo Fisher Scientific Inc. at outlicense@thermofisher.com for any desired use of LIFE MATERIALS beyond the scope of a) to c) above. |
必要書類 | 提供依頼書 ![]() ![]() 提供同意書 (MTA, 非営利学術目的用)[Word ![]() ![]() 提供同意書 (MTA, 営利目的用)[Word ![]() 手続きの概要は、「提供申込みについて[link]」をご覧ください。 |
---|---|
MTAに書く使用条件 | 発表に際し、理研BRCから入手したことを明記すること。 付加的使用条件: pRc/CMVについて: a) The modified pRc/CMV, and their descendants (collectively, LIFE MATERIALS), should be used for pre-clinical/non-human, research use only. b) LIFE MATERIALS shall not be used for any commercial purposes. c) LIFE MATERIALS shall not be transferred beyond the specified recipient. d) Recipient must contact Thermo Fisher Scientific Inc. at outlicense@thermofisher.com for any desired use of LIFE MATERIALS beyond the scope of a) to c) above. |
Catalog # | Resource name | Shipping form | Fee |
---|---|---|---|
RDB07018 | pCMFlag_hsNFKB1 | DNA solution |
JPY 9,460 (not-for-profit academic purpose) JPY 18,920 (for-profit-research purpose) plus cost of shipping containers, dry ice (if required) and shipping charge |
Materials & Methods section:
The pCMFlag_hsNFKB1 was provided by the RIKEN BRC through the National BioResource Project of the MEXT, Japan (cat. RDB07018). |
Reference section:
Further references such as user reports and related articles (go to bottom)
RIKEN BRC has sequenced portions of this material for quality test.
Please review the QC test results indicated by icon as well as clone information before placing your order.
Test sheet | RDB08125_A5Af.pdf ![]() |
---|
Nucleotide sequence of a portion of this resource (if available).
Primer: CMV-Forward Sequence file: RDB08125_A5Afa.seq ![]() |
---|
>07018_08125_A5Af_CMV-Forward_G08_20.ab1 1 ATTTCACCTC CCGCCCCATT GACGCAATGG GCGGTAGGCG TGTACGGCCC GGAGGTCTAT 61 ATAAGCAGAG CTCTCTGGCT AACTAGAGAA CCCACTGCTT ACTGGCTTAT CGAAATTAAT 121 ACGACTCACT ATAGGGAGAC CCAAGCTGAA TTCACCATGG ACTACAAGGA CGATGACGAT 181 AAGGCGGCCG CAGAAGATGA TCCATATTTG GGAAGGCCTG AACAAATGTT TCATTTGGAT 241 CCTTCTTTGA CTCATACAAT ATTTAATCCA GAAGTATTTC AACCACAGAT GGCACTGCCA 301 ACAGCAGATG GCCCATACCT TCAAATATTA GAGCAACCTA AACAGAGAGG ATTTCGTTTC 361 CGTTATGTAT GTGAAGGCCC ATCCCATGGT GGACTACCTG GTGCCTCTAG TGAAAAGAAC 421 AAGAAGTCTT ACCCTCAGGT CAAAATCTGC AACTATGTGG GACCAGCAAA GGTTATTGTT 481 CAGTTGGTCA CAAATGGAAA AAATATCCAC CTGCATGCCC ACAGCCTGGT GGGAAAACAC 541 TGTGAGGATG GGATCTGCAC TGTAACTGCT GGACCCAAGG ACATGGTGGT CGGCTTCGCA 601 AACCTGGGTA TACTTCATGT GACAAAGAAA AAAGTATTTG AAACACTGGA AGCACGAATG 661 ACAGAGGCGT GTATAAGGGG CTATAATCCT GGACTCTTGG TGCACCCTGA CCTTGCCTAT 721 TTGCAAGCAG AAGGTGGAGG GGACCGGCAG CTGGGAGATC GGGAAAAAGA GCTAATCCGC 781 CAAGCAGCTC TGCAGCAGAC CAAGGAGATG GACCTCAGCG TGGTGCGGCT CATGTTTACA 841 GCTTTTCTTC CGGATAGCAC TGGCAGCTTC ACAAGGCGCC TGGAACCCGT GGTATCAGAC 901 GCCATCTATG ACAGTAAAGC CCCCCAATGC ATCCAACTTG AAAATTTGTA AGAATGGGAC 961 AGGGACAGCT GGATGTGTGA CTGGGAGGGG AGGGAAATTT ATCTTCTTTT GTGACAAAGT 1021 TCAGAAAGAT GGACATCCAG ATTTCGATTT TTATGAAAGA AGAGAAATTG ATGTAGTCTG 1081 AAAGGATTGC AGATTTTTCC CTCCACAAGA ATGGTCATAG CAACTAAAT // |
Primer: BGH_rev Sequence file: RDB08125_A5Afb.seq ![]() |
>07018_08125_A5Af_BGHrev_H08_23.ab1 1 GGCTGCATTT AGGTGACTAT AGAATAGGGC CCTCTAGATG CATGCTCGAG CGGCCCTAAA 61 TTTTGCCTTC TAGAGGTCCT TCCTGCCCAT AATCATGGGG CATTTTGTTG AGAGTTAGCA 121 GTGAGGCACC ACTGGTCAGA GACTCGGTAA AGCTGAGTTT GCGGAAGGAT GTCTCCACGC 181 CGCTGTCGCA GACACTGTCA CTGTCTCGGA GCTCGTCTAT TTGCTGCCTT GTGGAGGCAG 241 GCGAGAGAGG CAGCGAGTGG GCCTGAGAGG TGGTCTTCAC TGGGCTGGAG GCTGCCTGGA 301 TCACTTCAAT TGCTTCGGTG TAGCCCATTT GTCTCAGGGC CTCCACCAGC TCTCTGACTG 361 TACCCCCAGA GACCTCATAG TTGTCCATAA GTGTTTTGGA AGGAGCAGGA CTCAGCCGGA 421 AGGCATTATT AAGTATCCCC AGACCTAATT TCTGCGCCAG AGTAGCCCAG TTTTTGTCTG 481 GATCAGGAAT TTCTAGTAAC TTATACAGCT GCAGCTTCAC ATCTTCAGCC AGCTGTTTCA 541 TGTCTCCTTG TGCTAGTAAA TCATCAGATG TAAACTCTGG CTCATATGGT TTCCCATTTA 601 ATATGTCAAA TACCTGCCAG CTGGTGGCCA TATCTAGAGG CGTGGTTCCA GGCACAACTC 661 CTTCATCCTC TCCTGCATTT TCCCAAGAGT CATCCAGGTC ATAGAGAGGC TCAAAGTTCT 721 CCACCAGGGG ATCTGCTCCT GCTGCTTTGA GAAGAGCTGC CAGCCTGGTG GACCCTCTCC 781 CAGCTGCTAT ATGCAGGGGT GTGGTTCCAT CGTAGGTAGT ACTGTCCACG TGGGCATCAC 841 CCTCCAGGAG CAGGCAGCCT GCCAATGAGA TGTTGTCGTG CTCCACAGCC AGGTGCAGTG 901 CTGTGCGCCC GGACTTCTGC TCCTGAGCAT TGACGTCAGC CCCAGCGGCC CACCAGCAGC 961 AGCAAACATG GGCAGGCTAT TGCTCATCAT GGCTAGATGA ATGGCATTTC AGACCGGTCC 1021 CCGTTGGGGT GATCAGAAGT TAGTTGCCTG CTTTTTGTTG CTTTGGAGGT AGATACTGAG 1081 ACTTTAATCA TGGATCGTTC GTTGGCCAAG CA // |
Please visit Sequencing and PCR primers for primer information.
Original, user report and related articles
Featured content